Autres langues AstraZeneca PLC Buenos Aires S.E.

Actions

AZN

ARDEUT112489

Produits pharmaceutiques

Cours en clôture 29/09/2026 Varia. 5j. Varia. 1 janv.
66 275,00 ARS -1,45% Graphique intraday de AstraZeneca PLC -1,23% -6,06%

Autres langues

29/09 AstraZeneca's $2 Billion Investment in Summit Therapeutics Seen as 'Win-Win,' UBS Says
29/09 European Equities Decline in Tuesday Trading; BlackRock, Vanguard Face Pressure as European Banks Launch ETFs
29/09 British Shares End Lower Amid Credit, Shop Price Inflation Reports; Vesuvius Surges
29/09 Global markets live: Nvidia, Meta, Anthropic, OpenAI, Boeing…
29/09 Afternoon Meeting: La renta variable desafía la presión
29/09 Aktien trotzen dem Druck
29/09 Pharma sector doubles down on AI to slash costs, timelines
29/09 Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Investors Weigh Tech Rebound
29/09 Stocks Defy the Pressure
29/09 US Equity Futures Slightly Higher Pre-Bell Amid Elevated Treasury Yields, Lack of Progress in US-Iran Talks
29/09 Stocks Rise Pre-Bell as Investors Weigh Growing AI Safety Concerns
29/09 S&P 500 flat as higher bond yields counter tech optimism
29/09 Borsa Usa, futures stabili, rimbalzo tech si scontra con cautela su greggio
29/09 Top Premarket Gainers
29/09 Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial Collaboration
29/09 Summit soars after $2 billion investment from AstraZeneca for cancer therapies
29/09 AstraZeneca invests $2bn in Summit Therapeutics
29/09 US stock futures flat as tech bounce meets crude-driven caution
29/09 FTSE 100 hits two-week low as energy stocks slide
29/09 WINNERS & LOSERS: Vesuvius soars on bid; Zigup lifts outlook
29/09 Hutchmed says AstraZeneca files US application for Orpathys
29/09 Hutchmed Lung-Cancer Fighting Drug Submitted to FDA for Approval
29/09 Stocks rise as pharma and miners advance
29/09 Astra files US cancer NDA; Close Bros loss narrows
29/09 Morning Meeting: Los bonos elevan la presión
Aucun résultat pour cette recherche